ResIn’s own Michael Head is in the UK national media today, talking about pneumonia investments. The Guardian newspaper has a supplement on antibiotic resistance, in support of the WHO’s World Antibiotic Awareness Week. See Michael on page 9 in the paper version, online link to a fuller article, or view the electronic version of the supplement (also page 9).
As part of the Research Investments in Global Health study (ResIn, www.researchinvestments.org), you may be interested in this our recent paper, led by colleague Joseph Fitchett and with Rifat Atun as senior author – we described funding for ebola R&D in the years prior to the 2014 outbreak and the responsive funding during the first year of the outbreak, covering $1 billion of investments from US and UK government, Wellcome, Gates etc. We’ve charted the funder, destination of those funds, and what they’re for (e.g. vaccine, diagnostics, therapeutics).
Now published ‘online first’ at Journal of Global Health
Paper is here – http://www.jogh.org/documents/issue201602/jogh-06-020703.XML
PDF is here – http://www.jogh.org/documents/issue201602/jogh-06-020703.pdf